Title:
経口用医薬組成物
Document Type and Number:
Japanese Patent JP5798642
Kind Code:
B2
Abstract:
The present invention provides an FTD and TPI-containing oral pharmaceutical composition which can be orally administered and is stable even under high humidity conditions. An oral pharmaceutical composition comprising ±,±,±-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1H,3H)-pyrimidine dione hydrochloride as an active ingredient; and being substantially free of an additive comprising a metal salt.
Inventors:
Onishi Keito
Tetsuo Ogata
Tetsuo Ogata
Application Number:
JP2013558723A
Publication Date:
October 21, 2015
Filing Date:
February 14, 2013
Export Citation:
Assignee:
Taiho Pharmaceutical Co., Ltd.
International Classes:
A61K31/7072; A61K9/20; A61K9/28; A61K31/513; A61K47/10; A61K47/12; A61K47/26; A61K47/32; A61K47/36; A61K47/38; A61K47/44; A61P35/00; A61P43/00
Domestic Patent References:
| JP2001131075A | ||||
| JP11322604A | ||||
| JP2005112744A | ||||
| JP2005314413A | ||||
| JP2007284390A |
Foreign References:
| WO2006080327A1 | ||||
| WO1996030346A1 |
Attorney, Agent or Firm:
Alga Patent Office, a patent business corporation
Toshio Takano
Toshio Nakajima
Masaki Murata
Hiroto Yamamoto
Toshio Takano
Toshio Nakajima
Masaki Murata
Hiroto Yamamoto